Medicare Enrolled
Dr. Joseph Mace, MD
Hematology · St Petersburg, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mace from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mace?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mace
Dr. Joseph Mace is a hematology specialist in St Petersburg, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mace performed 151,910 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mace received a total of $19,815 from 85 pharmaceutical and/or device companies across 553 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mace is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 36% volume in FL
$19,815 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 85939 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗151,910
Medicare services
Top 36% in FL for hematology
Not available
Unique patients (not deduplicated)
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
50,760 | $0 | $2 |
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
36,900 | $0 | $1 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
23,700 | $0 | $5 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
10,200 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 10,010 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 5,220 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
2,950 | $6 | $23 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,265 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,584 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,421 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,370 | $1 | $28 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
713 | $10 | $69 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
476 | $95 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 464 | $0 | $9 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
436 | $1 | $2 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
408 | $65 | $239 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
394 | $22 | $84 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
334 | $2 | $41 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
321 | $48 | $189 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
306 | $1 | $6 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
249 | $98 | $378 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
237 | $15 | $56 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
198 | $12 | $61 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
140 | $1 | $3 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
108 | $136 | $474 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
98 | $10 | $42 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
86 | $22 | $79 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
86 | $6 | $69 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
84 | $2 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
80 | $49 | $178 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
69 | $16 | $59 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
61 | $25 | $156 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
42 | $25 | $89 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $131 | $556 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
30 | $94 | $285 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
27 | $2 | $8 |
| New patient office visit, complex (60-74 min) | 24 | $144 | $585 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
15 | $4 | $10 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
14 | $28 | $156 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
7.7% high complexity
89.5% medium
2.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,815
Total received (2018-2024)
Avg $2,831/year across 7 years
Top 24% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
85
Companies
553
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,891
2023
$2,715
2022
$1,838
2021
$56
2020
$352
2019
$9,469
2018
$2,494
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$342
PFIZER INC.
$300
Daiichi Sankyo Inc.
$215
E.R. Squibb & Sons, L.L.C.
$177
Takeda Pharmaceuticals U.S.A., Inc.
$163
Lilly USA, LLC
$159
AstraZeneca Pharmaceuticals LP
$142
GlaxoSmithKline, LLC.
$121
Gilead Sciences, Inc.
$103
Astellas Pharma US Inc
$93
Janssen Biotech, Inc.
$84
PharmaEssentia USA Corporation
$79
Incyte Corporation
$77
Fennec Pharmaceuticals, Inc.
$73
Blueprint Medicines Corporation
$65
ARRAY BIOPHARMA INC
$65
SOBI, INC
$55
Eisai Inc.
$51
Celgene Corporation
$42
Pharmacosmos Therapeutics Inc.
$40
Sumitomo Pharma America, Inc.
$40
TAIHO ONCOLOGY, INC.
$37
Dendreon Pharmaceuticals LLC
$35
ABBVIE INC.
$34
SpringWorks Therapeutics, Inc.
$32
EMD Serono, Inc.
$24
Acrotech Biopharma Inc.
$24
Aveo Pharmaceuticals, Inc.
$22
Ipsen Biopharmaceuticals, Inc
$21
Stemline Therapeutics Inc.
$21
Novo Nordisk Inc
$20
Merck Sharp & Dohme LLC
$19
Genentech USA, Inc.
$18
Exelixis Inc.
$18
Karyopharm Therapeutics Inc.
$18
SHIELD THERAPEUTICS INC
$17
PUMA BIOTECHNOLOGY, INC.
$15
Janssen Pharmaceuticals, Inc
$14
CSL Behring
$13
Rigel Pharmaceuticals, Inc.
$6
Top 3 companies account for 29.6% of 2024 payments
All-time payments by company (2018-2024) ›
Spectrum Pharmaceuticals Inc.
$7,889
Novartis Pharmaceuticals Corporation
$1,471
Bayer HealthCare Pharmaceuticals Inc.
$949
E.R. Squibb & Sons, L.L.C.
$724
PFIZER INC.
$632
Daiichi Sankyo Inc.
$556
Janssen Biotech, Inc.
$488
Lilly USA, LLC
$469
Gilead Sciences, Inc.
$404
Celgene Corporation
$388
GENZYME CORPORATION
$376
AstraZeneca Pharmaceuticals LP
$339
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Amgen Inc.
$299
Takeda Pharmaceuticals U.S.A., Inc.
$295
Astellas Pharma US Inc
$234
GlaxoSmithKline, LLC.
$220
Genentech USA, Inc.
$183
Seagen Inc.
$182
Incyte Corporation
$168
Exelixis Inc.
$153
Stemline Therapeutics Inc.
$151
Merck Sharp & Dohme Corporation
$148
EMD Serono, Inc.
$146
Blueprint Medicines Corporation
$111
SANOFI-AVENTIS U.S. LLC
$99
PharmaEssentia USA Corporation
$98
SOBI, INC
$95
ABBVIE INC.
$94
Eisai Inc.
$93
Merck Sharp & Dohme LLC
$89
ARRAY BIOPHARMA INC
$81
TAIHO ONCOLOGY, INC.
$80
Kite Pharma, Inc.
$78
Janssen Pharmaceuticals, Inc
$78
Fennec Pharmaceuticals, Inc.
$73
Seattle Genetics, Inc.
$72
Ipsen Biopharmaceuticals, Inc
$70
Puma Biotechnology, Inc.
$59
Pharmacosmos Therapeutics Inc.
$59
EISAI INC.
$58
Sumitomo Pharma America, Inc.
$56
Karyopharm Therapeutics Inc.
$54
Taiho Oncology, Inc.
$53
CSL Behring
$52
AbbVie, Inc.
$48
Novocure Inc.
$45
Acrotech Biopharma Inc.
$44
Foundation Medicine, Inc.
$43
Sysmex Inostics Inc
$41
Array BioPharma Inc.
$40
Novo Nordisk Inc
$37
Bayer Healthcare Pharmaceuticals Inc.
$37
Global Blood Therapeutics, Inc.
$36
JAZZ PHARMACEUTICALS INC.
$35
Dendreon Pharmaceuticals LLC
$35
PUMA BIOTECHNOLOGY, INC.
$34
Rigel Pharmaceuticals, Inc.
$34
TerSera Therapeutics LLC
$34
SpringWorks Therapeutics, Inc.
$32
Regeneron Healthcare Solutions, Inc.
$28
Alexion Pharmaceuticals, Inc.
$27
Kyowa Kirin, Inc.
$26
Aurobindo Pharma USA, Inc.
$26
Lexicon Pharmaceuticals, Inc.
$26
Pharmacyclics LLC, an AbbVie Company
$24
Aveo Pharmaceuticals, Inc.
$22
MorphoSys, US Inc.
$20
CTI BioPharma Corp.
$20
AbbVie Inc.
$20
Pharmacyclics LLC, An AbbVie Company
$19
Allergan Inc.
$19
AMAG Pharmaceuticals, Inc.
$18
Myriad Genetic Laboratories, Inc.
$18
GE HealthCare
$17
Organon LLC
$17
SHIELD THERAPEUTICS INC
$17
BeiGene USA, Inc.
$17
Myovant Sciences Inc.
$16
AVEO Pharmaceuticals, Inc.
$16
Alnylam Pharmaceuticals Inc.
$14
Dova Pharmaceuticals
$14
Sysmex America, Inc.
$12
Clovis Oncology, Inc.
$12
EUSA Pharma (US) LLC
$11
Top 3 companies account for 52.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CERDELGA · CYRAMZA · Cabometyx · Creon · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · ERLEADA · EVENITY · EXKIVITY · Enhertu · Erleada · FARESTON · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · GAZYVA · GIVLAARI · HEMGENIX · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Idelvion · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Pomalyst · Poteligeo · REBLOZYL · RYBREVANT · Rebinyn · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SHINGRIX · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Sylvant · TABRECTA · TASIGNA · TECVAYLI · TUKYSA · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · XALKORI · XARELTO · XN Series · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZENPEP · ZEPZELCA · ZOLADEX · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
42
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH BAYFRONT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mace is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mace experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Mace performed 50,760 filgrastim injection (zarxio) for white blood cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mace receive payments from pharmaceutical companies?
Yes. Dr. Mace received a total of $19,815 from 85 companies across 553 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mace's costs compare to other hematologists in St Petersburg?
Dr. Mace's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mace) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in St Petersburg
Browse hematologists in St Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Spectrum Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Spectrum Pharmaceuticals Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology